Target Global
-
DATABASE (388)
-
ARTICLES (713)
Khosla Ventures is a Silicon Valley-based VC, founded in 2004 by Indian-born founder of tech pioneer Sun Microsystems Vinod Khosla. The company has no specific interest in terms of sector but heavily favors “large problems that are amenable to technology solutions” and invests in so-called high potential 'black swans´. Healthcare is a strong focus and its most recent investments include in the Portuguese home physiotherapy tech solution SWORD Health's 2021 $85m Series C and $25m Series B rounds besides its 2020 $17m Series A round which it led. Khosla has over $5bn under management and more than 70 staff, with investments in more than 700 startups, leading more than one-third. Other recent investments include in the July 2021 $75m Series C round of Indian personal health and fitness app HealthifyMe and, the same month, in the $12.5m Series A round of US commercial real estate app for tenants and property managers Jones.
Khosla Ventures is a Silicon Valley-based VC, founded in 2004 by Indian-born founder of tech pioneer Sun Microsystems Vinod Khosla. The company has no specific interest in terms of sector but heavily favors “large problems that are amenable to technology solutions” and invests in so-called high potential 'black swans´. Healthcare is a strong focus and its most recent investments include in the Portuguese home physiotherapy tech solution SWORD Health's 2021 $85m Series C and $25m Series B rounds besides its 2020 $17m Series A round which it led. Khosla has over $5bn under management and more than 70 staff, with investments in more than 700 startups, leading more than one-third. Other recent investments include in the July 2021 $75m Series C round of Indian personal health and fitness app HealthifyMe and, the same month, in the $12.5m Series A round of US commercial real estate app for tenants and property managers Jones.
CMO and co-founder of Tezign
Guo was named a Global Shaper by the World Economic Forum in 2014 and was on Forbes’ 2017 30 Under 30 Asia list. A graduate of the China Central Academy of Fine Arts, she has organized art exhibitions in countries such as Italy, Spain and Germany.
Guo was named a Global Shaper by the World Economic Forum in 2014 and was on Forbes’ 2017 30 Under 30 Asia list. A graduate of the China Central Academy of Fine Arts, she has organized art exhibitions in countries such as Italy, Spain and Germany.
Cane Investments is a private investment firm based in Irvington, New York, that specializes in early-stage investments in the media and communications sectors. It has nine companies in its portfolio. The firm most recently invested in autonomous and connected vehicle communication technology Veniam's US$22m Series B round in 2016. Other portfolio companies include wireless power startup uBeam and HR software company GetHired.com.
Cane Investments is a private investment firm based in Irvington, New York, that specializes in early-stage investments in the media and communications sectors. It has nine companies in its portfolio. The firm most recently invested in autonomous and connected vehicle communication technology Veniam's US$22m Series B round in 2016. Other portfolio companies include wireless power startup uBeam and HR software company GetHired.com.
Greycroft is a New York-based VC, established in 2006, that currently has 113 companies in its portfolio. It has interests in multiple sectors but a preference for A.I. and Big Data technologies underpinning them. It has managed 35 exits to date including Farfetch and Huffington Post. Its recent investments include in the US$60m Series C financing round of multilingual AI-driven translation platform Unbabel and in the US$22m Series A round of Kheiron, a breast cancer-detecting health tech.
Greycroft is a New York-based VC, established in 2006, that currently has 113 companies in its portfolio. It has interests in multiple sectors but a preference for A.I. and Big Data technologies underpinning them. It has managed 35 exits to date including Farfetch and Huffington Post. Its recent investments include in the US$60m Series C financing round of multilingual AI-driven translation platform Unbabel and in the US$22m Series A round of Kheiron, a breast cancer-detecting health tech.
Everbright New Economy USD Fund
Launched in 2018, Everbright New Economy USD Fund (New Economy Fund) is under the umbrella of China Everbright, a Hong Kong-listed financial conglomerate. The New Economy Fund started from an inaugural fund of US$483m, with US$150m from Bahrain-based asset manager Investcorp. It invests mainly in the e-commerce, smart retail and artificial intelligence sectors. In November 2019, China Everbright and Investcorp announced they will co-manage Investcorp New Economy Fund I and explore the opportunity to establish a successor private equity fund, jointly managed by the two parties, that will target China’s tech sector.
Launched in 2018, Everbright New Economy USD Fund (New Economy Fund) is under the umbrella of China Everbright, a Hong Kong-listed financial conglomerate. The New Economy Fund started from an inaugural fund of US$483m, with US$150m from Bahrain-based asset manager Investcorp. It invests mainly in the e-commerce, smart retail and artificial intelligence sectors. In November 2019, China Everbright and Investcorp announced they will co-manage Investcorp New Economy Fund I and explore the opportunity to establish a successor private equity fund, jointly managed by the two parties, that will target China’s tech sector.
Asabys Partners is a VC firm based in Barcelona and invests mainly in the healthtech and biopharma industries. Backed by Sabadell Bank, the VC now has offices in Spain, UK, Switzerland and Israel. Asabys Partners aims to accelerate technology breakthroughs in the fields of science and medicine by supporting a network of industry experts and talent.Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70m and Banc Sabadell as anchor investor. Main areas of investment include Biopharma, MedTech and Digital Therapeutics.
Asabys Partners is a VC firm based in Barcelona and invests mainly in the healthtech and biopharma industries. Backed by Sabadell Bank, the VC now has offices in Spain, UK, Switzerland and Israel. Asabys Partners aims to accelerate technology breakthroughs in the fields of science and medicine by supporting a network of industry experts and talent.Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70m and Banc Sabadell as anchor investor. Main areas of investment include Biopharma, MedTech and Digital Therapeutics.
Founded in 1969, Hong Kong-based Sun Hung Kai & Co is an investment company listed in the Hong Kong Stock Exchange. Its founder, Fung King-hey, is also the co-founder of Sun Hung Kai Properties. It invests mainly in finance, fintech, health insurance, media and technology sectors. The company has about HKD 43bn in assets and is the main shareholder of UA Finance and Everbright Sun Hung Kai.
Founded in 1969, Hong Kong-based Sun Hung Kai & Co is an investment company listed in the Hong Kong Stock Exchange. Its founder, Fung King-hey, is also the co-founder of Sun Hung Kai Properties. It invests mainly in finance, fintech, health insurance, media and technology sectors. The company has about HKD 43bn in assets and is the main shareholder of UA Finance and Everbright Sun Hung Kai.
This private Portuguese healthcare group was established in 2000 and based in Lisbon. It made its first investment in a startup in 2019 when it led the €600,000 seed round of medtech UpHill, a SaaS for healthcare professionals to keep up-to-speed on the latest clinical treatments and protocols using AI. The group’s Hospital da Luz was one of UpHill’s first customers.
This private Portuguese healthcare group was established in 2000 and based in Lisbon. It made its first investment in a startup in 2019 when it led the €600,000 seed round of medtech UpHill, a SaaS for healthcare professionals to keep up-to-speed on the latest clinical treatments and protocols using AI. The group’s Hospital da Luz was one of UpHill’s first customers.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in Berlin in 2016, Atlantic Food Labs’ mission is to support startups with the potential to feed 10bn people by 2050. It has supported 20 companies to date and its most recent investments include in the German healthy last-minute delivery service Gorillas’ $290m Series B round and in the €5.9m seed round of B2B German retail connection service Magaloop in March 2021.
Founded in Berlin in 2016, Atlantic Food Labs’ mission is to support startups with the potential to feed 10bn people by 2050. It has supported 20 companies to date and its most recent investments include in the German healthy last-minute delivery service Gorillas’ $290m Series B round and in the €5.9m seed round of B2B German retail connection service Magaloop in March 2021.
Yingke PE was founded in 2010 and is headquartered in Shanghai. By the end of 2020, it had managed assets worth nearly RMB 50bn. In May 2021, it closed the RMB 10bn Yingke Science & Technology Innovation Industrial Fund. Over 90% of its funds come from financial institutions, state-owned enterprises and listed companies. Yingke PE has invested in more than 200 companies, focusing on biopharmaceuticals, core technology and upgraded consumption. Since its founding, the company has exited 53 projects, with an internal rate of return up to 54%.
Yingke PE was founded in 2010 and is headquartered in Shanghai. By the end of 2020, it had managed assets worth nearly RMB 50bn. In May 2021, it closed the RMB 10bn Yingke Science & Technology Innovation Industrial Fund. Over 90% of its funds come from financial institutions, state-owned enterprises and listed companies. Yingke PE has invested in more than 200 companies, focusing on biopharmaceuticals, core technology and upgraded consumption. Since its founding, the company has exited 53 projects, with an internal rate of return up to 54%.
Openspace Ventures (formerly NSI Ventures)
Originally formed in 2014 as NSI Ventures, Openspace Ventures makes investments in technology companies based in Southeast Asia. Led by Shane Chesson and Hian Goh, Openspace Ventures used to be a part of Northstar Group, a private equity firm primarily invested in the financial services, retail, energy and telecom sectors. In 2018, Chesson and Goh took NSI Ventures independent and rebranded it as Openspace Ventures. They still maintain links with Northstar, with Northstar managing partner Patrick Goh becoming senior advisor to Openspace.
Originally formed in 2014 as NSI Ventures, Openspace Ventures makes investments in technology companies based in Southeast Asia. Led by Shane Chesson and Hian Goh, Openspace Ventures used to be a part of Northstar Group, a private equity firm primarily invested in the financial services, retail, energy and telecom sectors. In 2018, Chesson and Goh took NSI Ventures independent and rebranded it as Openspace Ventures. They still maintain links with Northstar, with Northstar managing partner Patrick Goh becoming senior advisor to Openspace.
Silicon Valley-based Tyche Partners was founded in 2015 to invest in hardtech sectors such as SpaceTech, IoT devices, cloud and enterprise infrastructure. Managing partner Weijie Yun is a computer science engineer and veteran entrepreneur as founder and CEO of Telegent Systems, AIP Networks and SiTek.The VC firm currently has 18 startups in its portfolio, including being lead investor for the $12m Series A round of Vence in May 2021. Vence is a California-based producer of virtual fencing wearables for livestock management.
Silicon Valley-based Tyche Partners was founded in 2015 to invest in hardtech sectors such as SpaceTech, IoT devices, cloud and enterprise infrastructure. Managing partner Weijie Yun is a computer science engineer and veteran entrepreneur as founder and CEO of Telegent Systems, AIP Networks and SiTek.The VC firm currently has 18 startups in its portfolio, including being lead investor for the $12m Series A round of Vence in May 2021. Vence is a California-based producer of virtual fencing wearables for livestock management.
Country Garden Venture Capital
Founded in 2019, Country Garden Venture Capital is the corporate venturing arm of Chinese real estate developer Country Garden. With its parent company as the cornerstone investor, it is focused on certain sectors of the supply chain, namely, technology, healthcare and consumption. As of March 2021, Country Garden Venture Capital has invested around RMB 10bn in over 50 companies with an average return above 80%. Among them, 15 have achieved unicorn status ($1bn in valuation), while four have successfully gone public.
Founded in 2019, Country Garden Venture Capital is the corporate venturing arm of Chinese real estate developer Country Garden. With its parent company as the cornerstone investor, it is focused on certain sectors of the supply chain, namely, technology, healthcare and consumption. As of March 2021, Country Garden Venture Capital has invested around RMB 10bn in over 50 companies with an average return above 80%. Among them, 15 have achieved unicorn status ($1bn in valuation), while four have successfully gone public.
Advisor, board member, co-founder of NovoNutrients
Brian Sefton has been co-founder, a board member and a part-time advisor at NovoNutrients, a San Francisco-based biotech manufacturer of alt-protein produced from fermentation and CO2 since it was founded in 2017. In 2009, he co-founded research entity Oakbio, from which NovoNutrients evolved, and was its President and CTO. Sefton was CTO and President at NovoNutrients and also co-CEO and Chief Scientist at Oakbio until 2021 when he became the CEO at San Francisco-based fermentation commercialization startup Sincarne. Between 2005 and 2011, Sefton was also CEO at pharma research company Pharmadyn, working on drugs development for Alzheimer's Disease, and, for three of those years, was also Managing Partner of Stratsyn, a consultancy specializing in creation, development, management and fund raising for not-for-profit organizations. Sefton’s earlier posts include: directing nanotechnology commercialization and investment company Nanosig for three years, CEO of Silicon Valley’s Fastlane, a high-profile pioneer in real-time network traffic and security analysis for six years; and, simultaneously, being CEO at Bluebox Communications, developing high-end network security applications and appliances for Fortune 500 companies and the US government.Sefton holds an MBA from Santa Clara University in California and a bachelor’s degree in biochemistry from the University of California, Berkeley
Brian Sefton has been co-founder, a board member and a part-time advisor at NovoNutrients, a San Francisco-based biotech manufacturer of alt-protein produced from fermentation and CO2 since it was founded in 2017. In 2009, he co-founded research entity Oakbio, from which NovoNutrients evolved, and was its President and CTO. Sefton was CTO and President at NovoNutrients and also co-CEO and Chief Scientist at Oakbio until 2021 when he became the CEO at San Francisco-based fermentation commercialization startup Sincarne. Between 2005 and 2011, Sefton was also CEO at pharma research company Pharmadyn, working on drugs development for Alzheimer's Disease, and, for three of those years, was also Managing Partner of Stratsyn, a consultancy specializing in creation, development, management and fund raising for not-for-profit organizations. Sefton’s earlier posts include: directing nanotechnology commercialization and investment company Nanosig for three years, CEO of Silicon Valley’s Fastlane, a high-profile pioneer in real-time network traffic and security analysis for six years; and, simultaneously, being CEO at Bluebox Communications, developing high-end network security applications and appliances for Fortune 500 companies and the US government.Sefton holds an MBA from Santa Clara University in California and a bachelor’s degree in biochemistry from the University of California, Berkeley
Heptasense wins trust at a time of (lax) global surveillance
There may be some 700 million surveillance cameras running worldwide in today's age of global security threats, yet 98% of them are unmonitored. A Lisbon-based startup is promising real-time response and greater reliability in security tech
Xtrem Biotech, an agritech startup from Granada, seeks global expansion
With its research roots in the University of Granada, Xtrem Biotech was named one of the world's most innovative agtech spin-offs by accelerator TERRA Food & AgTech
Mediktor: AI medical diagnosis app wants to improve global health outcomes
NLP-based triage and diagnosis tool has achieved a 91% accuracy rate in clinical trials and raised €3 million funding
GoWithFlow: Scaling ERP platform for sustainable mobility in global transportation markets
Portugal’s CEiiA spin-off leads the way to manage smart transportation systems of cities and corporations to boost fleet performance by reducing CO2 emissions and maintenance costs
From state to BAT, China backs startups for global AI dominance
Finance, automobile, retail and healthcare seen to lead China’s advances and gains in AI, as part of a RMB 10 trillion economy by 2030
China's WeDoctor offers free coronavirus consultations globally in English and Chinese
WeDoctor lets anyone in the world send queries to doctors who fought to save lives in China's most affected Covid-19 districts, and now helping people overseas to stay safe during the pandemic
South Summit wants to go global, as it launches Brazilian chapter
CEO Marta del Castillo on South Summit’s LatAm, Asia expansion plans; its net-zero pledge; her new role as co-head to further drive growth and more
Li Zexiang and his game-changing plans to take Chinese robotics global
An early supporter of drone giant DJI, Professor Li Zexiang is building robotics hubs across China to pivot homegrown enterprises into global players
OLIO: Zero food waste app expands with new product categories, going global
Recent $43m Series B funding will let sustainability app more than triple hiring, add homemade products and household goods to product listings
Innovate big or go home: logistics unicorn YH Global eyes “Belt and Road” gold
The world’s first logistics firm to become a unicorn at Series A is a model of innovation in China. More overseas growth is next
European agritech is the new global focus, as startup investments nearly doubled in 2019
Last year, European agritech surpassed China for the first time in investments received, with openings in multiple subsectors from big data to blockchain
Lalibela Global-Networks: A mission to digitalize, move Africa's healthcare system to the cloud
This year’s Web Summit winner, Lalibela Global-Networks, is digitalizing Africa’s paper-based healthcare system in a low-cost, low-code way to save lives and make healthcare affordable
Smart Agrifood Summit 2021: A global innovation ecosystem is needed to catch up with other sectors
Investors from SVG Ventures/THRIVE, Pinduoduo and others agree that players must join forces to boost agrifood tech investment, internationally and across the value chain
Clarity AI uses machine learning and data analytics to effectively assess and score environmental, social and governance performance of companies and investment portfolios
RatedPower: Creating solar power plant designs in minutes
The Spanish startup is helping solar plants expand exponentially worldwide and revolutionizing the sector with its automated software
Sorry, we couldn’t find any matches for “Target Global”.